Dongsung Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dongsung Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Wooridul Pharmaceutical Limited
sales of 79.89 billion Korean Won [US$70.95 million]
of which 100%
Binex Company Ltd
(78.03 billion Korean Won [US$69.29 million]
of which 83%
was Pharmaceutical), and
Hanall Biopharma Company Limited
(84.23 billion Korean Won [US$74.80 million]
of which 100%
was Medicinals and Bontanicals).
Dongsung Pharmaceutical Company Limited reported sales of 82.39 billion Korean Won (US$73.16 million)
December of 2017.
increase of 3.3%
versus 2016, when the company's sales were 79.72 billion Korean Won.
This was the third consecutive year of growth at Dongsung Pharmaceutical Company Limited.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Dongsung Pharmaceutical Company Limited had sales
of 84.58 billion Korean Won.
Sales of Pharmaceutical Segment saw an increase
that was more than double the company's growth rate: sales were up
7.2% in 2017, from
70.70 billion Korean Won to 75.82 billion Korean Won.
Not all segments of Dongsung Pharmaceutical Company Limited experienced an increase in sales in 2017:
sales of Cosmetics/toilet Preparation Segment fell 27.2% to 6.57 billion Korean Won.